SEELOS THERAPEUTICS, INC. — Form D

SEELOS THERAPEUTICS, INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-30. The offering totals $1.1M. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Margaret W DalesandroDirectorNew York, NY
Brian LianDirectorNew York, NY
Richard W PascoeDirectorNew York, NY
Michael W GolembiewskiExecutive OfficerNew York, NY
Raj MehraExecutive OfficerNew York, NY
Raj MehraDirectorNew York, NY
Richard W PascoeExecutive OfficerNew York, NY
Margaret J DalesandroDirectorNew York, NY
Daniel J O'ConnorDirectorNew York, NY
Michael J GolembiewskiExecutive OfficerNew York, NY
Kleanthis G XanthopoulosDirectorSan Diego, CA
Judith W DunnDirectorNew York, NY
Paul V MaierDirectorDeer Park, IL
Henry J EsberDirectorNewton, MA
Henry J EsberExecutive OfficerNewton, MA
Richard J BermanDirectorTUCSON, AZ
Mark WestgateExecutive OfficerRancho Cordova, CA
Robin L SmithDirectorSalt Lake City, UT
WENDELL W WIERENGADirectorSAN DIEGO, CA
SANDFORD D SMITHDirectorSAN DIEGO, CA
NEIL D MORTONExecutive OfficerSAN DIEGO, CA
RUSTY W RAYDirectorSAN DIEGO, CA
BRIAN D DORSEYExecutive OfficerSAN DIEGO, CA
CATHERINE D BOVENIZERExecutive OfficerSAN DIEGO, CA
Vivian B LiuDirectorSan Diego, CA

Other filings by this issuer (8)

FiledFormOfferingSold
2024-05-31D$2.0M
2024-02-14D$3.6M
2020-09-14D$5.6M
2019-08-30D$4.0M
2017-09-27D$3.7M$3.7M
2016-10-13D$3.7M$3.7M
2010-03-18D$4.0M$4.0M
2010-03-10D$2.5M$2.3M

More